Hwg Holdings LP Eli Lilly & CO Transaction History

Hwg Holdings LP

$283 Million
Q3 2024

A detailed history of Hwg Holdings LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Hwg Holdings LP holds 6,125 shares of LLY stock, worth $4.76 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares

6,125

Previous 16,459 62.79%

Holding current value

$4.76 Million

Previous $14.9 Million 63.59%

% of portfolio

1.92%

Previous 5.47%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$772.14 - $960.02 $7.98 Million - $9.92 Million	-10,334 Reduced 62.79%	6,125 $5.43 Million
Q2 2024 Aug 19, 2024	BUY	$724.87 - $909.04 $8.55 Million - $10.7 Million	11,794 Added 252.82%	16,459 $14.9 Million
Q4 2023 Jan 04, 2024	BUY	$525.19 - $619.13 $91,383 - $107,728	174 Added 3.87%	4,665 $2.72 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $1.7 Million - $2.34 Million	3,900 Added 659.9%	4,491 $2.41 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $207,287 - $277,167	591 New	591 $277,000
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $23,938 - $29,749	-102 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$224.85 - $279.04 $22,934 - $28,462	102 New	102 $28,000
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $63,920 - $82,748	-389 Closed	0 $0
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $184,600 - $244,271	-1,415 Reduced 78.44%	389 $66,000
Q3 2020 Oct 02, 2020	SELL	$146.22 - $169.13 $123,409 - $142,745	-844 Reduced 31.87%	1,804 $267,000
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $351,145 - $422,599	2,574 Added 3478.38%	2,648 $435,000
Q4 2019 Jan 09, 2020	BUY	$106.92 - $132.43 $7,912 - $9,799	74 New	74 $10,000

Others Institutions Holding LLY

# of Institutions

3,918

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $738B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Hwg Holdings LP with notifications on news.

Account